Cargando…

Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic

Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamaddon, Maryam, Gilja, Helena, Wang, Ling, Oliveira, J. Miguel, Sun, Xiaodan, Tan, Rongwei, Liu, Chaozong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Multimedia Press Co., Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255817/
https://www.ncbi.nlm.nih.gov/pubmed/35837659
http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002
_version_ 1784740999671578624
author Tamaddon, Maryam
Gilja, Helena
Wang, Ling
Oliveira, J. Miguel
Sun, Xiaodan
Tan, Rongwei
Liu, Chaozong
author_facet Tamaddon, Maryam
Gilja, Helena
Wang, Ling
Oliveira, J. Miguel
Sun, Xiaodan
Tan, Rongwei
Liu, Chaozong
author_sort Tamaddon, Maryam
collection PubMed
description Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-surgical therapeutic options or less invasive surgical treatments are no longer effective. These are major surgical procedures which have a substantial impact on patients’ quality of life and lifetime risk of requiring revision surgery. Treatments using regenerative methods such as tissue engineering methods have been established and are promising for the early treatment of cartilage degeneration in osteoarthritis joints. In this approach, 3-dimensional scaffolds (with or without cells) are employed to provide support for tissue growth. However, none of the currently available tissue engineering and regenerative medicine products promotes satisfactory durable regeneration of large cartilage defects. Herein, we discuss the current regenerative treatment options for cartilage and osteochondral (cartilage and underlying subchondral bone) defects in the articulating joints. We further identify the main hurdles in osteochondral scaffold development for achieving satisfactory and durable regeneration of osteochondral tissues. The evolution of the osteochondral scaffolds – from monophasic to multiphasic constructs – is overviewed and the osteochondral scaffolds that have progressed to clinical trials are examined with respect to their clinical performances and their potential impact on the clinical practices. Development of an osteochondral scaffold which bridges the gap between small defect treatment and joint replacement is still a grand challenge. Such scaffold could be used for early treatment of cartilage and osteochondral defects at early stage of osteoarthritis and could either negate or delay the need for joint replacements.
format Online
Article
Text
id pubmed-9255817
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Chinese Medical Multimedia Press Co., Ltd
record_format MEDLINE/PubMed
spelling pubmed-92558172022-07-13 Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic Tamaddon, Maryam Gilja, Helena Wang, Ling Oliveira, J. Miguel Sun, Xiaodan Tan, Rongwei Liu, Chaozong Biomater Transl Review Osteoarthritis is a degenerative joint disease, typified by the loss in the quality of cartilage and bone at the interface of a synovial joint, resulting in pain, stiffness and reduced mobility. The current surgical treatment for advanced stages of the disease is joint replacement, where the non-surgical therapeutic options or less invasive surgical treatments are no longer effective. These are major surgical procedures which have a substantial impact on patients’ quality of life and lifetime risk of requiring revision surgery. Treatments using regenerative methods such as tissue engineering methods have been established and are promising for the early treatment of cartilage degeneration in osteoarthritis joints. In this approach, 3-dimensional scaffolds (with or without cells) are employed to provide support for tissue growth. However, none of the currently available tissue engineering and regenerative medicine products promotes satisfactory durable regeneration of large cartilage defects. Herein, we discuss the current regenerative treatment options for cartilage and osteochondral (cartilage and underlying subchondral bone) defects in the articulating joints. We further identify the main hurdles in osteochondral scaffold development for achieving satisfactory and durable regeneration of osteochondral tissues. The evolution of the osteochondral scaffolds – from monophasic to multiphasic constructs – is overviewed and the osteochondral scaffolds that have progressed to clinical trials are examined with respect to their clinical performances and their potential impact on the clinical practices. Development of an osteochondral scaffold which bridges the gap between small defect treatment and joint replacement is still a grand challenge. Such scaffold could be used for early treatment of cartilage and osteochondral defects at early stage of osteoarthritis and could either negate or delay the need for joint replacements. Chinese Medical Multimedia Press Co., Ltd 2020-12-28 /pmc/articles/PMC9255817/ /pubmed/35837659 http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002 Text en https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review
Tamaddon, Maryam
Gilja, Helena
Wang, Ling
Oliveira, J. Miguel
Sun, Xiaodan
Tan, Rongwei
Liu, Chaozong
Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title_full Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title_fullStr Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title_full_unstemmed Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title_short Osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
title_sort osteochondral scaffolds for early treatment of cartilage defects in osteoarthritic joints: from bench to clinic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255817/
https://www.ncbi.nlm.nih.gov/pubmed/35837659
http://dx.doi.org/10.3877/cma.j.issn.2096-112X.2020.01.002
work_keys_str_mv AT tamaddonmaryam osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT giljahelena osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT wangling osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT oliveirajmiguel osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT sunxiaodan osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT tanrongwei osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic
AT liuchaozong osteochondralscaffoldsforearlytreatmentofcartilagedefectsinosteoarthriticjointsfrombenchtoclinic